IMMUNOPRISM
Live / Registered — Registered (as of 01 Oct 2019)
What this means for you
Registered since 01 Oct 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88202739
- Registration number
- 5871582
- Mark type
- Stylized text
- Filed
- 21 Nov 2018
- Published for opposition
- 16 Jul 2019
- Registered
- 01 Oct 2019
- Attorney of record
- Christine K. Au-Yeung
Goods and services
- Class 001 — Chemicals: Assays and reagents for use in genetic research, gene expression analysis, biomarker analysis, and RNA-based immune profiling other than for medical or veterinary use
- Class 005 — Pharmaceuticals: Medical diagnostic kits comprised of reagents and assays for testing and analyzing genes, nucleic acids, and biological molecules
- Class 042 — Scientific and technological services: Scientific research and development; scientific research and development in the field of gene expression analysis, biomarker analysis, and RNA-based immune profiling assay, and immune profiling; DNA analysis services for scientific research purposes; product development services, namely, developing reagents and reagent kits for use in preparing, detecting, analyzing, and sequencing nucleic acids and other biological molecules in the field of genetic research
Owner
- COFACTOR GENOMICS, INC., SAN FRANCISCO, CA, US
- COFACTOR GENOMICS, INC., SAN FRANCISCO, CA, US
- COFACTOR GENOMICS, INC., SAN FRANCISCO, CA, US
Prosecution history
- 01 Oct 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 01 Oct 2019 — REGISTERED-PRINCIPAL REGISTER
- 16 Jul 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 16 Jul 2019 — PUBLISHED FOR OPPOSITION
- 26 Jun 2019 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 12 Jun 2019 — NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
- 11 Jun 2019 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 11 Jun 2019 — USE AMENDMENT ACCEPTED
- 20 May 2019 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 20 May 2019 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 17 May 2019 — ASSIGNED TO LIE
- 09 May 2019 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 28 Feb 2019 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 28 Feb 2019 — NON-FINAL ACTION E-MAILED
- 28 Feb 2019 — NON-FINAL ACTION WRITTEN